Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts

被引:27
作者
Jianhua Cui
Dipak K. Das
Aldo Bertelli
Arpad Tosaki
机构
[1] University of Connecticut School of Medicine,Cardiovascular Research Center
[2] University of Milano,Department of Pharmacology
[3] University of Debrecen,Department of Pharmacology, Health Science Center
来源
Molecular and Cellular Biochemistry | 2003年 / 254卷
关键词
L-carnitine; acetyl-L-carnitine; propionyl-L-carnitine; infarct size; apoptosis; isolated rat heart; ischemia/reperfusion;
D O I
暂无
中图分类号
学科分类号
摘要
The study aimed to examine whether L-carnitine and its derivatives, acetyl-L-carnitine and propionyl-L-carnitine, were equally effective and able to improve postischemic cardiac function, reduce the incidence of reperfusion-induced ventricular fibrillation, infarct size, and apoptotic cell death in ischemic/reperfused isolated rat hearts. There are several studies indicating that L-carnitine, a naturally occurring amino acid and an essential cofactor, can improve mechanical function and substrate metabolism not only in hypertrophied or failing myocardium but also in ischemic/reperfused hearts. The effects of L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine, on the recovery of heart function, incidence of reperfusion-induced ventricular fibrillation (VF), infarct size, and apoptotic cell death after 30 min ischemia followed by 120 min reperfusion were studied in isolated working rat hearts. Hearts were perfused with various concentrations of L-carnitine (0.5 and 5 mM), acetyl-L-carnitine (0.5 and 5 mM), and propionyl-L-carnitine (0.05, 0.5, and 5 mM), respectively, for 10 min before the induction of ischemia. Postischemic recovery of CF, AF, and LVDP was significantly improved in all groups perfused with 5 mM of L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine. Significant postischemic ventricular recovery was noticed in the hearts perfused with 0.5 mM of propionyl-L-carnitine, but not with the same concentration of L-carnitine or L-acetyl carnitine. The incidence of reperfusion VF was reduced from its control value of 90 to 10% (p < 0.05) in hearts perfused with 5 mM of propionyl-L-carnitine only. Other doses of various carnitines failed to reduce the incidence of VF. The protection in CF, AF, LVDP, and VF reflected in a reduction in infarct size and apoptotic cell death in hearts treated with various concentrations of carnitine derivatives. The difference between effectiveness of various carnitines on the recovery of postischemic myocardium may be explained by different membrane permeability properties of carnitine and its derivatives.
引用
收藏
页码:227 / 234
页数:7
相关论文
共 156 条
[1]
Anand I(1998)Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure Cardiovasc Drugs Ther 12 291-299
[2]
Chandrashekhan Y(1998)Ionic and metabolic imbalance as potential factors of ischemia/reperfusion injury Am J Cardiol 82 K25-K29
[3]
De Giuli F(2000)Regulation of carbohydrate metabolism in ischemia and reperfusion Am Heart J 139 S115-S119
[4]
Pasini E(1983)Carnitine-metabolism and functions Physiol Rev 63 1420-1480
[5]
Mazzoletti A(1991)Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts J Biol Chem 266 8162-8170
[6]
Confortini R(1993)Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart J Biol Chem 268 25836-25845
[7]
Ferrari R(1997)Study of the effects of theophylline-related changes in total, free, short-chain acyl and long-chain acyl carnitine concentrations in rat heart Toxicology 121 205-213
[8]
El-Banani H(1999)Beneficial effects of propionyl-L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction Cardiovasc Res 42 607-615
[9]
Bernard M(2001)Antioxidant changes in the hypertrophied heart due to energy metabolic disorder Basic Res Cardiol 96 431-438
[10]
Cozzone P(1991)Effects of propionyl-L-carnitine on mechanical function of isolated and perfused hearts Cardiovasc Drugs Ther 5 109-115